2010Jilin yixueRequires access

Observation of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B

Yongping Wang

Open publisher page 0 citations

Abstract

Objective To observe the effect of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B.Methods 150 patients with chronic hepatitis B were divided into 3 groups,each group had 50 patients.The patients in combination group received lamivudine and interferonα-2b therapy for one year,the patients in lamivudine group and interferon group received lamivudine and interferonα-2b therapy respectively for one year.Results After one year,the HBV DNA loss and HBeAg/anti-HBe seroconversion in combination group were 86% and 48% respectively,they were higher than in lamivudine group and interferon group(P0.05),YMDD mutations were detected in 1 patients in combination group(2%) but 8 patients in lamivudine group(16%).Conclusion Combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B get a better effect and decrease YMDD mutation.

About this research paper

What this paper is about

Objective To observe the effect of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B.Methods 150 patients with chronic hepatitis B were divided into 3 groups,each group had 50 patients.The patients in combination group received lamivudine and interferonα-2b therapy for one year,the patients in lamivudine group and interferon group received lamivudine and interferonα-2b therapy respectively for one year.Results After one year,the HBV DNA loss and HBeAg/anti-HBe seroconversion in combination group were 86% and 48% respectively,they were higher than in lamivudine group and interferon group(P0.05),YMDD mutations were detected in 1 patients in combination group(2%) but 8 patients in lamivudine group(16%).Conclusion Combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B get a better effect and decrease YMDD mutation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B.Methods 150 patients with chronic hepatitis B were divided into 3 groups,each group had 50 patients.The patients in combination group received lamivudine and interferonα-2b therapy for one year,the patients in lamivudine group and interferon group received lamivudine and interferonα-2b therapy respectively for one year.Results After one year,the HBV DNA loss and HBeAg/anti-HBe seroconversion in combination group were 86% and 48% respectively,they were higher than in lamivudine group and interferon group(P0.05),YMDD mutations were detected in 1 patients in combination group(2%) but 8 patients in lamivudine group(16%).Conclusion Combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B get a better effect and decrease YMDD mutation.

Key concepts: Lamivudine, Medicine, Interferon, HBeAg, Chronic hepatitis, Seroconversion, Gastroenterology, Combination therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B — Research Paper | ScholarLens